Supplementary Data from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma is Mediated by BCL2

Jian-Zhong Tang,Xiang-Jun Kong,Jian Kang,Graeme C. Fielder,Michael Steiner,Jo K. Perry,Zheng-Sheng Wu,Zhinan Yin,Tao Zhu,Dong-Xu Liu,Peter E. Lobie

DOI: https://doi.org/10.1158/1535-7163.22485557

2023-01-01

Abstract:Supplementary Data from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2

What problem does this paper attempt to address?

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Wenqun Zhong,Zebin Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23907869

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Table S1 from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma is Mediated by BCL2

Jian-Zhong Tang,Xiang-Jun Kong,Jian Kang,Graeme C. Fielder,Michael Steiner,Jo K. Perry,Zheng-Sheng Wu,Zhinan Yin,Tao Zhu,Dong-Xu Liu,Peter E. Lobie

DOI: https://doi.org/10.1158/1535-7163.22485554

2023-01-01

Abstract:Table S1a: Expression of ARTN, GFRA2, GFRA3 and RET are compared between human lung carcinoma and normal lung tissues; Table S1b: Correlation between expression of ARTN and parameters of human lung carcinoma; Table S1c: Correlation between expression of GFRA1 and parameters of human lung carcinoma; Table S1d: Correlation between expression of GFRA2 and parameters of human lung carcinoma;Table S1e: Correlation between expression of GFRA3 and parameters of human lung carcinoma; Table S1f: Correlation between expression of RET and parameters of human lung carcinoma.
Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Qianying Guo,Hao Wang,Jiahao Duan,Wenwu Luo,Rongrong Zhao,Yuting Shen,Bijun Wang,Siqi Tao,Yi Sun,Qian Ye,Xiaomin Bi,Hui Yuan,Qiang Wu,Peter E. Lobie,Tao Zhu,Sheng Tan,Xing Huang,Zhengsheng Wu

DOI: https://doi.org/10.1158/0008-5472.22432764.v1

2023-01-01

Abstract:Supplementary Data from An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer
Artemin-stimulated Progression of Human Non-Small Cell Lung Carcinoma is Mediated by BCL2.

Jian-Zhong Tang,Xiang-Jun Kong,Jian Kang,Graeme C. Fielder,Michael Steiner,Jo K. Perry,Zheng-Sheng Wu,Zhinan Yin,Tao Zhu,Dong-Xu Liu,Peter E. Lobie

DOI: https://doi.org/10.1158/1535-7163.mct-09-1077

2010-01-01

Molecular Cancer Therapeutics

Abstract:AbstractWe herein show that Artemin (ARTN), one of the glial cell line–derived neurotrophic factor family of ligands, promotes progression of human non–small cell lung carcinoma (NSCLC). Oncomine data indicate that expression of components of the ARTN signaling pathway (ARTN, GFRA3, and RET) is increased in neoplastic compared with normal lung tissues; increased expression of ARTN in NSCLC also predicted metastasis to lymph nodes and a higher grade in certain NSCLC subtypes. Forced expression of ARTN stimulated survival, anchorage-independent, and three-dimensional Matrigel growth of NSCLC cell lines. ARTN increased BCL2 expression by transcriptional upregulation, and inhibition of BCL2 abrogated the oncogenic properties of ARTN in NSCLC cells. Forced expression of ARTN also enhanced migration and invasion of NSCLC cells. Forced expression of ARTN in H1299 cells additionally resulted in larger xenograft tumors, which were highly proliferative, invasive, and metastatic. Concordantly, either small interfering RNA–mediated depletion or functional inhibition of endogenous ARTN with antibodies reduced oncogenicity and invasiveness of NSCLC cells. ARTN therefore mediates progression of NSCLC and may be a potential therapeutic target for NSCLC. Mol Cancer Ther; 9(6); 1697–708. ©2010 AACR.
Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Mengyu Xie,Hong Zheng,Ranjna Madan-Lala,Wenjie Dai,Nicholas T. Gimbrone,Zhihua Chen,Fumi Kinose,Sarah A. Blackstone,Keiran S.M. Smalley,W. Douglas Cress,Eric B. Haura,Uwe Rix,Amer A. Beg

DOI: https://doi.org/10.1158/0008-5472.22422753

2023-01-01

Abstract:Supplementary Methods for Xie et al, MEK inhibition modulates cytokine response to mediate therapeutic efficacy in lung cancer
Supplementary Data 1 from HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer

Tao Jiang,Qiqi Jin,Jiahao Wang,Fengying Wu,Jian Chen,Gongyan Chen,Yunchao Huang,Jianhua Chen,Ying Cheng,QiMing Wang,Yueyin Pan,Jianying Zhou,Jianhua Shi,Xingxiang Xu,LiZhu Lin,Wei Zhang,Yiping Zhang,Yunpeng Liu,Yong Fang,Jifeng Feng,Zhehai Wang,Sheng Hu,Jian Fang,Yongqian Shu,Jiuwei Cui,Yi Hu,Wenxiu Yao,Xingya Li,Xiaoyan Lin,Rui Wang,Yongsheng Wang,Wei Shi,Gaohua Feng,Jun Ni,Beibei Mao,Dandan Ren,Huaibo Sun,Henghui Zhang,Luonan Chen,Caicun Zhou,Shengxiang Ren

DOI: https://doi.org/10.1158/1078-0432.23791953.v1

2023-01-01

Abstract:Supplementary Materials
Supplementary Figure S2 from Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Jhanelle E. Gray,Andreas Saltos,Tawee Tanvetyanon,Eric B. Haura,Ben Creelan,Scott J. Antonia,Michael Shafique,Hong Zheng,Wenjie Dai,James J. Saller,Zhihua Chen,Nishan Tchekmedyian,Kristen Goas,Ram Thapa,Theresa A. Boyle,Dung-Tsa Chen,Amer A. Beg

DOI: https://doi.org/10.1158/1078-0432.22471758.v1

2023-01-01

Abstract:Approach to assess levels of monocytic and PMN MDSC in patient PBMCs.
Supplementary Materials 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Lang,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524615.v1

2023-01-01

Abstract:PDF file - 129K, Sweave report depicting complete codes use for microarray analysis of paired adjacent and contralateral airways
Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Lixing Zhang,Hefen Sun,Fangyu Zhao,Peixiang Lu,Ge Chen,Hong Li,Helei Hou,Mingxia Yan,Taoyang Chen,Guoping Jiang,Haiyang Xie,Ying Cui,Xiaowu Huang,Jia Fan,Ming Yao,Jinjun Li

DOI: https://doi.org/10.1158/0008-5472.22395141

2023-01-01

Abstract:PDF file - 47K, Sequences of primers used in this study
Supplementary Table 1 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Lixing Zhang,Hefen Sun,Fangyu Zhao,Ping Lu,Chao Ge,Hong Li,Helei Hou,Mingxia Yan,Taoyang Chen,Guoping Jiang,Haiyang Xie,Ying Cui,Xiaowu Huang,Jia Fan,Ming Yao,Jinjun Li

DOI: https://doi.org/10.1158/0008-5472.22395144.v1

2023-01-01

Abstract:PDF file - 82K, Antibodies used in this study
Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Pedro Rocha,Jiexin Zhang,Raquel Laza-Briviesca,Alberto Cruz-Bermúdez,Neus Bota-Rabassedas,Beatriz Sanchez-Espiridon,Kazuhito Funai,Carmen Behrens,Wei Lü,Ximing Tang,Apar Pataer,Edwin R. Parra,Cara Haymaker,Junya Fujimoto,Stephen G. Swisher,John V. Heymach,Don L. Gibbons,John Lee,Boris Sepesi,Tina Cascone,Luisa M. Solis,Mariano Provencio,Ignacio I. Wistuba,Humam Kadara

DOI: https://doi.org/10.1158/1078-0432.22486923

2023-01-01

Abstract:Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC
Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Qi Shen,Jun Li,Junhua Mai,Zhe Zhang,Andrew Fisher,Xiaoyan Wu,Zhaoqi Li,Maricela R. Ramirez,Shuqing Chen,Haifa Shen

DOI: https://doi.org/10.1038/s41419-018-1040-9

2018-01-01

Abstract:Lung cancer is the leading cause of death in the United States, with non-small cell lung cancers (NSCLC) accounting for 85% of all cases. By analyzing the expression profile of the pro-apoptotic and anti-apoptotic proteins, we have assigned NSCLCs into two distinct groups. While single agent treatment with the BCL-2/BCL-xL/BCL-w inhibitor ABT-263 (navitoclax) did not trigger apoptosis in either group, cells with a moderate to high level of MCL-1 expression were sensitive to ABT-263 treatment when MCL-1 expression was suppressed with a gene-specific siRNA. In contrast, those with a low MCL-1 expression did not undergo apoptosis upon combination treatment with ABT-263 and MCL-1 siRNA. Further studies revealed that cells with a low MCL-1 expression had low mitochondrial priming, and treatment with the chemotherapy drug docetaxel raised the mitochondrial priming level and consequently sensitized cells to ABT-263. These results establish a rationale for molecular profiling and a therapeutic strategy to treat NSCLC patients with pro-apoptotic anti-cancer drugs based on their MCL-1 expression level.
Data Supplement from Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells

Xiaoli Ma,Jia Liu,Jiang Wu,Xiyun Yan,Peng Wu,Yong Liu,Shuang Li,Yuan Tian,Yang Cao,Gang Chen,Li Meng,Gang Xu,Shixuan Wang,Yunping Lu,Ding Ma,Jianfeng Zhou

DOI: https://doi.org/10.1158/1078-0432.22442330.v1

2023-01-01

Abstract:Data Supplement from Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells
Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Yufei Wang,Man Zhao,Lina Zhao,Yu Geng,Guanghao Li,Lin Chen,Jingxuan Yu,Hongfeng Yuan,Huihui Zhang,Haolin Yun,Ying Yuan,Guowen Wang,Jinyan Feng,Liang Xu,Shuai Wang,Chunyu Hou,Guang Yang,Ningning Zhang,Wei Lu,Xiaodong Zhang

DOI: https://doi.org/10.1158/0008-5472.22433561.v1

2023-01-01

Abstract:Supplementary materials and methods, Supplementary figures, Supplementary figure legends, Supplementary tables
Supplementary Data from Suppression of Anoikis by skp2 Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Xiao-Chun Wang,Yu-Peng Wu,Bo Ye,De-Chen Lin,Yan-Bin Feng,Zi-Qiang Zhang,Xin Xu,Ya-Ling Han,Yan Cai,Jin-Tang Dong,Qi-Min Zhan,Min Wu,Ming-Rong Wang

DOI: https://doi.org/10.1158/1541-7786.22518823

2023-01-01

Abstract:Supplementary Data from Suppression of Anoikis by SKP2 Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma
Supplementary Data from Translational Activation of ATF4 Through Mitochondrial Anaplerotic Metabolic Pathways is Required for DLBCL Growth and Survival

Meng Li,Matthew R. Teater,Jun Young Hong,Noel R. Park,Cihangir Duy,Hao Shen,Ling Wang,Zhengming Chen,Leandro Cerchietti,Shawn M. Davidson,Hening Lin,Ari M. Melnick

DOI: https://doi.org/10.1158/2643-3230.22544175.v1

2023-01-01

Abstract:Supplementary Data from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
Supplementary Data from a20, &Lt;i>abin-1/2&Lt;/i>, and card11 Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma

Gaochao Dong,Estelle Chanudet,Naiyan Zeng,Alex Appert,Yun‐Wen Chen,Wing‐Yan Au,Rifat Hamoudi,A. James Watkins,Hongtao Ye,Hongxiang Liu,Zifen Gao,Shih‐Sung Chuang,Gopesh Srivastava,Ming‐Qing Du

DOI: https://doi.org/10.1158/1078-0432.22442261.v1

2023-01-01

Abstract:Supplementary Figures S1-S2; Supplementary Tables S1-S2.
Supplementary Figure S1 from Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study

Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li,Chuan He,Hang Su,Hui Zhou,Kunyan Li,Siguo Hao,Xuelan Zuo,Jianyuan Wu,Dengju Li,Meng Wu,Xiuhua Sun,Junyuan Qi,Zhen Cai,Zengjun Li,Yijing Li,Yanhua Huang,Jie Shen,Zhenyu Xiao,Jun Zhu

DOI: https://doi.org/10.1158/1078-0432.25515657

2024-01-01

Abstract:Supplementary Figure S1. Progression-free survival by lymphoma subtype.
Supplementary Data from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Mengmeng Zhang,Kaiwen Zhou,Zilin Wang,Ting Liu,Laura E. Stevens,Filipa Lynce,Wendy Y. Chen,Sui Peng,Yubin Xie,Duanyang Zhai,Qianjun Chen,Yawei Shi,Huijuan Shi,Zhongyu Yuan,Xiaoping Li,Juan Xu,Zhenhai Cai,Jianping Guo,Nan Shao,Ying Lin

DOI: https://doi.org/10.1158/0008-5472.25964564.v1

2024-01-01

Abstract:Including Supplementary materials and methods and Supplementary Figure S1-6

Supplementary Data from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma is Mediated by BCL2

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Table S1 from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma is Mediated by BCL2

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Artemin-stimulated Progression of Human Non-Small Cell Lung Carcinoma is Mediated by BCL2.

Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Supplementary Data 1 from HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer

Supplementary Figure S2 from Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Supplementary Materials 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133<sup>+</sup> Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Table 1 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Data Supplement from Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplementary Data from Suppression of Anoikis by <i>skp2</i> Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Supplementary Data from Translational Activation of ATF4 Through Mitochondrial Anaplerotic Metabolic Pathways is Required for DLBCL Growth and Survival

Supplementary Data from <i>a20</i>, &Lt;i>abin-1/2&Lt;/i>, and <i>card11</i> Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma

Supplementary Figure S1 from Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study

Supplementary Data from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Supplementary Data from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma is Mediated by BCL2

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Table S1 from Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma is Mediated by BCL2

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Artemin-stimulated Progression of Human Non-Small Cell Lung Carcinoma is Mediated by BCL2.

Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Supplementary Data 1 from HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer

Supplementary Figure S2 from Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Supplementary Materials 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133&lt;sup&gt;+&lt;/sup&gt; Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Table 1 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Data Supplement from Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplementary Data from Suppression of Anoikis by &lt;i&gt;skp2&lt;/i&gt; Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Supplementary Data from Translational Activation of ATF4 Through Mitochondrial Anaplerotic Metabolic Pathways is Required for DLBCL Growth and Survival

Supplementary Data from &lt;i&gt;a20&lt;/i&gt;, &Lt;i&gt;abin-1/2&Lt;/i&gt;, and &lt;i&gt;card11&lt;/i&gt; Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma

Supplementary Figure S1 from Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study

Supplementary Data from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133<sup>+</sup> Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Data from Suppression of Anoikis by <i>skp2</i> Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Supplementary Data from <i>a20</i>, &Lt;i>abin-1/2&Lt;/i>, and <i>card11</i> Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma